Idemitsu Kosan Co.,Ltd.
Idemitsu Kosan Co.,Ltd. (IDKOF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Idemitsu Kosan Co.,Ltd. (IDKOF), featuring income statements, balance sheets, and cash flow data.
Idemitsu Kosan Co.,Ltd. (IDKOF) Income Statement & Financial Overview
Review Idemitsu Kosan Co.,Ltd. IDKOF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2313.76B | $2372.44B | $2243.74B | $2260.29B |
| Cost of Revenue | $2131.44B | $2211.29B | $2143.32B | $2014.76B |
| Gross Profit | $182.32B | $161.15B | $100.42B | $245.53B |
| Gross Profit Ratio | $0.08 | $0.07 | $0.04 | $0.11 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $143.41B | $135.20B | $125.60B | $123.02B |
| Operating Expenses | $143.41B | $135.20B | $125.60B | $123.02B |
| Total Costs & Expenses | $2274.85B | $2346.49B | $2268.92B | $2137.78B |
| Interest Income | $6.26B | $4.84B | $3.10B | $2.88B |
| Interest Expense | $4.97B | $3.21B | $4.47B | $4.08B |
| Depreciation & Amortization | $26.87B | $27.14B | $25.97B | $25.98B |
| EBITDA | $21.24B | $53.08B | $793.00M | $166.27B |
| EBITDA Ratio | $0.009 | $0.02 | $0.00 | $0.07 |
| Operating Income | $38.91B | $25.95B | -$25.18B | $122.51B |
| Operating Income Ratio | $0.02 | $0.01 | -$0.01 | $0.05 |
| Other Income/Expenses (Net) | -$47.45B | $10.19B | $19.73B | $13.70B |
| Income Before Tax | -$8.54B | $36.13B | -$5.45B | $136.22B |
| Income Before Tax Ratio | -$0.004 | $0.02 | -$0.002 | $0.06 |
| Income Tax Expense | $15.63B | $8.64B | -$9.49B | $41.57B |
| Net Income | -$23.40B | $28.01B | $4.42B | $95.02B |
| Net Income Ratio | -$0.01 | $0.01 | $0.002 | $0.04 |
| EPS | -$18.02 | $21.16 | $3.27 | $69.24 |
| Diluted EPS | -$18.02 | $21.16 | $3.27 | $69.24 |
| Weighted Avg Shares Outstanding | $1.30B | $1.32B | $1.35B | $1.37B |
| Weighted Avg Shares Outstanding (Diluted) | $1.30B | $1.32B | $1.35B | $1.37B |
The company's financials show resilient growth, with revenue advancing from $2260.29B in Q1 2024 to $2313.76B in Q4 2024. Gross profit remained healthy with margins at 8% in Q4 2024 compared to 11% in Q1 2024. Operating income hit $38.91B last quarter, sustaining a consistent 2% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $21.24B. Net income dropped to -$23.40B, while earnings per share reached -$18.02. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan